News

After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...
said on Wednesday it has achieved a "final victory" in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity ...
The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines ... vaccine infringes multiple patents that cover its own Spikevax shot. Among the claims is that ...
After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine ... Moderna's mRNA-1273 shot. The patent has been filed ...
A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...
said Wednesday it had achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger RNA (mRNA) Covid-19 vaccine. SK bioscience filed a nullity ...